FreeObituary Paul Engstrom, Fox Chase pioneer of cancer prevention, dies at 89 January 09, 2026Vol.52 No.1By Robert G. Uzzo
FreeObituary Patient advocate David Mitchell, 75, dies of multiple myeloma January 09, 2026Vol.52 No.1By Ellen V. Sigal
Sponsored Composite intelligence: How AI-driven biomarkers are setting the bar in immuno-oncology January 09, 2026Vol.52 No.1By Ofer Sharon, Michal Harel and Yehonatan Elon
PodcastThe Directors The Directors: Joann Sweasy and Robert Winn reflect on lessons learned during a tough yearFormer and current AACI presidents agree: strategic communication is key to safeguarding the future of cancer research December 19, 2025Vol.51 No.46By Claire Marie Porter and Paul Goldberg
Guest Editorial With streamlined, “sitevisitless” CCSG review in place, cancer centers remained stable in 2025 December 19, 2025Vol.51 No.46By Richard J. Jones
Should I have a drink tonight?In anticipation of the first holiday season since the surgeon general’s report on alcohol and cancer, we ask experts to weigh in December 19, 2025Vol.51 No.46By Jacquelyn Cobb
EditorialFree The Cancer Letter’s most-read stories of 2025As MAHA-led policies took hold, oncology navigated through uncertainty and turmoil December 19, 2025Vol.51 No.46By Katie Goldberg
Sponsored Mitochondrial-targeting drug attacks cancer cells from within December 19, 2025Vol.51 No.46By Hayley Kamin
Conversation with The Cancer Letter John Byrd brings blood cancer expertise to solid tumor, immunology powerhouse at UPMC December 12, 2025Vol.51 No.45By Jacquelyn Cobb and Paul Goldberg
Regulatory News FDA withdraws proposed rule for asbestos testing in talc-based cosmeticsIt’s anyone’s guess whether the agency is preparing to strengthen or relax talc regulation December 12, 2025Vol.51 No.45By Claire Marie Porter
